CHO Pharma, Inc.
6586.TWO
Price:
$30
Market Cap:
$6.42B
CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which is in Phase I/IIa clinical trials for the treatment of refractory non-Hodgkin lymphoma; CHO-A04, a humanized monoclonal antibody, which is in phase I...[Read more]
Industry
Biotechnology
IPO Date
2017-09-28
Stock Exchange
TWO
Ticker
6586.TWO
PE Ratio
[-28.04]
ROE
[-8.57%]
Current Ratio
[21.85]
Dividend Yield
[0%]
Enterprise Value
[6.27B]
Dividend History
The ROE as of December 2025 (TTM) for CHO Pharma, Inc. (6586.TWO) is -8.57%
According to CHO Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -8.57%. This represents a change of 98.40% compared to the average of -4.32% of the last 4 quarters.
CHO Pharma, Inc. (6586.TWO) Historical ROE (quarterly & annually)
How has 6586.TWO ROE performed in the past?
The mean historical ROE of CHO Pharma, Inc. over the last ten years is -14.08%. The current -8.57% ROE has changed -39.15% with respect to the historical average. Over the past ten years (40 quarters), 6586.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at -12.33%.
Average
-14.08%
Median
-13.46%
Minimum
-23.69%
Maximum
-7.72%
CHO Pharma, Inc. (6586.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of CHO Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.61%
Maximum Annual ROE = -7.72%
Minimum Annual Increase = -56.57%
Minimum Annual ROE = -23.69%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.72% | -24.95% |
| 2023 | -10.29% | -56.57% |
| 2022 | -23.69% | 100.61% |
| 2021 | -11.81% | -21.91% |
| 2020 | -15.12% | -4.51% |
CHO Pharma, Inc. (6586.TWO) Average ROE
How has 6586.TWO ROE performed in the past?
The current ROE of CHO Pharma, Inc. (6586.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.90%
5-year avg
-13.72%
10-year avg
-14.08%
CHO Pharma, Inc. (6586.TWO) ROE vs. Peers
How is 6586.TWO’s ROE compared to its peers?
CHO Pharma, Inc.’s ROE is greater than Mycenax Biotech Inc. (-25.50%), greater than Adimmune Corporation (-4.48%), greater than TaiGen Biopharmaceuticals Holdings Limited (-22.99%), greater than Pharmosa Biopharm Inc. (-15.24%), greater than OBI Pharma, Inc. (-79.60%), greater than AP Biosciences Inc (-25.56%), greater than Acepodia, Inc. (-11.14%), less than Sinphar Pharmaceutical Co.,Ltd. (9.51%), greater than BioGend Therapeutics Co., Ltd. (-15.67%), greater than Formosa Laboratories, Inc. (-0.80%),
| Company | ROE | Market cap |
|---|---|---|
| -25.50% | $6.72B | |
| -4.48% | $8.11B | |
| -22.99% | $7.90B | |
| -15.24% | $6.92B | |
| -79.60% | $7.59B | |
| -25.56% | $12.68B | |
| -11.14% | $9.65B | |
| 9.51% | $5.83B | |
| -15.67% | $4.75B | |
| -0.80% | $7.44B |
Build a custom stock screener for CHO Pharma, Inc. (6586.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CHO Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
CHO Pharma, Inc. (6586.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like CHO Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is CHO Pharma, Inc.'s ROE?
How is the ROE calculated for CHO Pharma, Inc. (6586.TWO)?
What is the highest ROE for CHO Pharma, Inc. (6586.TWO)?
What is the 3-year average ROE for CHO Pharma, Inc. (6586.TWO)?
What is the 5-year average ROE for CHO Pharma, Inc. (6586.TWO)?
How does the current ROE for CHO Pharma, Inc. (6586.TWO) compare to its historical average?